The blood-brain barrier constitutes a major obstacle to effective treatment of diseases affecting the central nervous system. A new strategy to target specifically the endothelium of diseased brain may allow the development of more effective gene-based therapies (pages 1215–1218).
References
Platt, F.M. & Lachmann, R.H. Biochim. Biophys. Acta 1793, 737–745 (2009).
Chen, Y.H., Chang, M. & Davidson, B.L. Nat. Med. 15, 1215–1218 (2009).
Girod, A. et al. Nat. Med. 5, 1052–1056 (1999).
Foust, K.D. et al. Nat. Biotechnol. 27, 59–65 (2009).
Young, P.P., Fantz, C.R. & Sands, M.S. Exp. Neurol. 188, 104–114 (2004).
Worgall, S. et al. Hum. Gene Ther. 19, 463–474 (2008).
Cavazzana-Calvo, M. et al. Blood 112, abstact 821 (2008).
Cearley, C.N. & Wolfe, J.H. J. Neurosci. 27, 9928–9940 (2007).
Work, L.M. et al. Mol. Ther. 13, 683–693 (2006).
Brooks, A.I. et al. Proc. Natl. Acad. Sci. USA 99, 6216–6221 (2002).
Gao, G.P. et al. Proc. Natl. Acad. Sci. USA 99, 11854–11859 (2002).
Schaffer, D.V., Koerber, J.T. & Lim, K.I. Annu. Rev. Biomed. Eng. 10, 169–194 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mingozzi, F., High, K. Gateway to the diseased brain. Nat Med 15, 1123–1124 (2009). https://doi.org/10.1038/nm1009-1123
Issue Date:
DOI: https://doi.org/10.1038/nm1009-1123
- Springer Nature America, Inc.